The FDA has approved Rybelsus to help reduce the risk of major cardiovascular events such as stroke, heart attack, or death in adults who have type 2 diabetes and who are at high risk for these events
---- Lubberding AF, Veedfald S, Achter JS, Nissen SD, Soattin L, Sorrentino A, Vega ET, Linz B, Eggertsen CHE, Mulvey J, Torng S, Larsen SA, Nissen A, Petersen LG, Bilir SE, Bentzen BH, Rosenkilde MM, Hartmann B, Liller TNB, Qazi S, Mller CH, Tfelt-Hansen J, Sattler SM, Jespersen T, Holst JJ, Lundby A
Summary Melanotan-II (MT-2) is a synthetic analog of alpha-melanocyte-stimulating hormone (-MSH) , primarily used to stimulate melanin production for sunless tanning
Report suspected side effects to the MHRA through the Yellow Card Scheme (yellowcard.mhra.gov.uk)